Multitarget AD inhibitor-1

Modify Date: 2024-01-09 17:24:05

Multitarget AD inhibitor-1 Structure
Multitarget AD inhibitor-1 structure
Common Name Multitarget AD inhibitor-1
CAS Number 2205015-77-4 Molecular Weight 430.62
Density N/A Boiling Point N/A
Molecular Formula C29H38N2O Melting Point N/A
MSDS N/A Flash Point N/A

 Use of Multitarget AD inhibitor-1


Multitarget AD inhibitor-1 is a selective and reversible butyrylcholinesterase (BuChE) inhibitor with IC50s of 7.22 μM and 1.55 μM for hBuChE and eqBuChE, respectively. Multitarget AD inhibitor-1 inhibits β-secretase (IC50hBACE-1=41.60 μM), amyloid β aggregation (IC50 Aβ=3.09 μM), tau aggregation (55% at 10 μM). Multitarget AD inhibitor-1, a diphenylpropylamine derivative, has the potential for multifunctional disease-modifying anti-Alzheimer’s[1].

 Names

Name Multitarget AD inhibitor-1

 Multitarget AD inhibitor-1 Biological Activity

Description Multitarget AD inhibitor-1 is a selective and reversible butyrylcholinesterase (BuChE) inhibitor with IC50s of 7.22 μM and 1.55 μM for hBuChE and eqBuChE, respectively. Multitarget AD inhibitor-1 inhibits β-secretase (IC50hBACE-1=41.60 μM), amyloid β aggregation (IC50 Aβ=3.09 μM), tau aggregation (55% at 10 μM). Multitarget AD inhibitor-1, a diphenylpropylamine derivative, has the potential for multifunctional disease-modifying anti-Alzheimer’s[1].
Related Catalog
In Vitro Multitarget AD inhibitor-1 (compound 10) selectively inhibits BuChE from equine serum (eqBuChE) and hBuChE over AChE from electric eel (eeAChE; 21.78% at 10 μM)[1]. Multitarget AD inhibitor-1 (10 μM) inhibits full-length tau aggregation with 44.4%[1].
References

[1]. Dawid Panek, et al. Design, Synthesis, and Biological Evaluation of 1-Benzylamino-2-hydroxyalkyl Derivatives as New Potential Disease-Modifying Multifunctional Anti-Alzheimer's Agents. ACS Chem Neurosci. 2018 May 16;9(5):1074-1094.

 Chemical & Physical Properties

Molecular Formula C29H38N2O
Molecular Weight 430.62